Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

METHOD OF STIMULATING PROLIFERATION AND DIFFERENTIATION OF HUMAN FETAL PANCREATIC CELLS EX VIVO

  • Read more about METHOD OF STIMULATING PROLIFERATION AND DIFFERENTIATION OF HUMAN FETAL PANCREATIC CELLS EX VIVO
US Patent 5,587,309
Filed on 1994-04-29

1,2-DIHYDROELLIPTICINES WITH ACTIVITY AGAINST CNS SPECIFIC CANCER CELL LINES

  • Read more about 1,2-DIHYDROELLIPTICINES WITH ACTIVITY AGAINST CNS SPECIFIC CANCER CELL LINES
US Patent 5,441,941
Filed on 1993-12-21

METHOD FOR THE LIPOSOMAL DELIVERY OF NUCLEIC ACIDS

  • Read more about METHOD FOR THE LIPOSOMAL DELIVERY OF NUCLEIC ACIDS
US Patent 5,908,635
Filed on 1994-08-05

ETS1-GENE: A HUMAN TUMOR SUPPRESSOR GENE

  • Read more about ETS1-GENE: A HUMAN TUMOR SUPPRESSOR GENE
US Patent 5,629,192
Filed on 1994-02-04

METHOD FOR DISCRIMINATING AND IDENTIFYING ALLELES IN COMPLEX LOCI

  • Read more about METHOD FOR DISCRIMINATING AND IDENTIFYING ALLELES IN COMPLEX LOCI
US Application 08/158,472
Filed on 1993-11-29

ISOLATION OF CELLULAR MATERIAL UNDER MICROSCOPIC VISUALIZATION

  • Read more about ISOLATION OF CELLULAR MATERIAL UNDER MICROSCOPIC VISUALIZATION
US Patent 5,843,644
Filed on 1994-03-01

REMOTE CANNULA REMOVAL CARTRIDGE AND HYPODERMIC SYRINGES

  • Read more about REMOTE CANNULA REMOVAL CARTRIDGE AND HYPODERMIC SYRINGES
US Patent 5,246,423
Filed on 1991-11-01

DIASTEREOSELECTIVE PROCESS LEADING TO A KEY INTERMEDIATE FOR THE PREPARATION OF FLUORINATED REVERSE TRANSCRIPTASE INHIBITORS

  • Read more about DIASTEREOSELECTIVE PROCESS LEADING TO A KEY INTERMEDIATE FOR THE PREPARATION OF FLUORINATED REVERSE TRANSCRIPTASE INHIBITORS
US Patent 5,498,719
Filed on 1994-01-31

CO2-INDEPENDENT GROWTH MEDIUM FOR MAINTENANCE AND PROPAGATION OF CELLS

  • Read more about CO2-INDEPENDENT GROWTH MEDIUM FOR MAINTENANCE AND PROPAGATION OF CELLS
US Application 08/164,687
Filed on 1993-12-09

Methods and Compositions for Stimulating and Inhibiting TGF-B Activity

  • Read more about Methods and Compositions for Stimulating and Inhibiting TGF-B Activity
US Application 08/106,120
Filed on 1993-08-13

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1593
  • Page 1594
  • Page 1595
  • Page 1596
  • Page 1597
  • Page 1598
  • Page 1599
  • Page 1600
  • Page 1601
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health